Stocks and Investing
Stocks and Investing
Mon, January 8, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, January 5, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Long Downgraded (ALLY) to Sell on, Jan 5th, 2024
David Long of Raymond James, Downgraded "Ally Financial Inc." (ALLY) to Sell on, Jan 5th, 2024.
David has made no other calls on ALLY in the last 4 months.
There are 9 other peers that have a rating on ALLY. Out of the 9 peers that are also analyzing ALLY, 5 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jason Goldberg of "Barclays" Maintained at Hold with Increased Target to $43 on, Tuesday, January 2nd, 2024
- Betsy Van Hees of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $31 on, Wednesday, December 13th, 2023
- Moshe Orenbuch of "TD Cowen" Initiated at Hold and Held Target at $28 on, Wednesday, November 1st, 2023
- Richard Shane of "JP Morgan" Maintained at Hold with Decreased Target to $27 on, Tuesday, October 17th, 2023
- Kevin Barker of "Piper Sandler" Maintained at Hold with Increased Target to $31 on, Friday, September 29th, 2023
These are the ratings of the 4 analyists that currently disagree with David
- Ryan Nash of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $37 on, Monday, December 18th, 2023
- Bill Carcache of "Wolfe Research" Upgraded from Hold to Buy and Held Target at $39 on, Thursday, November 30th, 2023
- Arren Cyganovich of "Citigroup" Maintained at Strong Buy with Decreased Target to $35 on, Thursday, October 19th, 2023
- James Fotheringham of "BMO Capital" Maintained at Buy with Decreased Target to $40 on, Thursday, October 19th, 2023
Contributing Sources